“There is some probability for a possible link between the second vaccine dose and the onset of myocarditis among young men aged 16 to 30,” the announcement reads. “This link was found to be stronger among the younger age group, 16 to 19, compared to other age groups. This link became weaker the older the vaccinated individual is. In most cases, myocarditis took the form of mild illness that passed within a few days.”
Israel’s Health Ministry has announced a possible association between Pfizer’sCOVID-19vaccineand heart inflammation among men aged 16 to 30.
Three teams of experts investigated the potential link to cases of myocarditis and submitted findings to the Ministry. Results involved 275 reported cases of myocarditis from December to May, 148 of whichoccurred around the time of vaccination. Some 27 cases cropped up after the initial dose against a backdrop of 5.4 million vaccinated individuals, while 121 cases occurred around administration of the second dose.
Nearly all cases were mild and mostly occurred in young men aged 16 to 19 post-second dose. Illnesses typically required four days of hospitalization.
“There is some probability for a possible link between the second vaccine dose and the onset of myocarditis among young men aged 16 to 30,” theannouncementreads. “This link was found to be stronger among the younger age group…
The Most Revolutionary Act 